Novel possibilities of antithrombotic therapy in patients with chronic heart failure

被引：0
|
作者：
Olbinskaya, LI [1 ]
Kolosova, K [1 ]
Nesterova, SG [1 ]
Egorova, TD [1 ]
Fedorova, AY [1 ]
机构：
[1] IM Sechenov Med Acad, Moscow 119881, Russia
来源：
KARDIOLOGIYA | 2005年 / 45卷 / 12期
关键词：
thrombosis; thromboembolism; venous; heart failure; chronic; enoxaparin;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Modern approaches to prevention of venous thromboembolic complications in patients with chronic heart failure are analyzed in this review which contains results of large studies of low molecular weight heparins. In MEDENOX trial the use of enoxaparin in medical patients was associated with 63% reduction of risk of thrombosis. The authors own experience showed that 2 weeks of therapy with enoxaparin in patients with chronic stage IIB-III heart failure caused significant lowering of soluble fibrin-monomer complexes, fibrinogen, and index of turbodynamic potential. These changes evidenced for decreased intravascular blood coagulation. Thus enoxaparin can be effectively used for prevention of thrombosis and thromboembolism in patients with chronic heart failure. Novel antithrombotic agents fondaparinux, idraparinux, ximelagatran, recombinant thrombomodulin are perspective medications for prevention of venous thromboses and embolism in medical patients.
引用
收藏
页码：93 / 98
页数：6
相关论文
共 50 条
  • [1] Antithrombotic therapy in heart failure
    Verheugt, F. W. A.
    NETHERLANDS HEART JOURNAL, 2012, 20 (04) : 176 - 178
  • [2] Antithrombotic therapy in heart failure
    F. W. A. Verheugt
    Netherlands Heart Journal, 2012, 20 : 176 - 178
  • [3] Antithrombotic therapy for congestive heart failure
    Chung, I
    Lip, GYH
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (01) : 36 - 47
  • [4] The Role of Antithrombotic Therapy in Heart Failure
    Chrysohoou, Christina
    Magkas, Nikolaos
    Antoniou, Christos-Konstantinos
    Manolakou, Panagiota
    Laina, Aggeliki
    Tousoulis, Dimitrios
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (23) : 2735 - 2761
  • [5] Antithrombotic therapy in congestive heart failure
    Adam, Oliver
    Boehm, Michael
    HERZ, 2008, 33 (01) : 20 - 24
  • [6] Antithrombotic therapy for stroke prevention in patients with heart failure
    Hyman D.
    Morales-Vidal S.
    Schneck M.J.
    Current Treatment Options in Cardiovascular Medicine, 2012, 14 (3) : 215 - 226
  • [7] Antithrombotic therapy for heart failure in sinus rhythm
    Subramaniam, Veeran
    Davis, Russell C.
    Shantsila, Eduard
    Lip, Gregory Y. H.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2009, 23 (06) : 705 - 717
  • [8] Antithrombotic Therapy in Heart Failure WATCHful Wondering
    Konstam, Marvin A.
    CIRCULATION, 2009, 119 (12) : 1559 - 1561
  • [9] Updated meta-analysis on antithrombotic therapy in patients with heart failure and sinus rhythm
    Hopper, Ingrid
    Skiba, Marina
    Krum, Henry
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 15 (01) : 69 - 78
  • [10] Antithrombotic Therapy in Patients With Chronic Kidney Disease
    Capodanno, Davide
    Angiolillo, Dominick J.
    CIRCULATION, 2012, 125 (21) : 2649 - 2661
12345